Press Releases
	The Angiogenesis Research Center is often featured in the lay and scientific press for its accomplishments over the years and for its scientific contributions to the field and its role in the care of hunderds of "no-option" patients. In this page, we will cite the most relevant press releases that directly affect our patients and collaborators.

• High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response

• Angiogenesis and Direct Myocardial Revascularization textbook is a comprehensive discussion of the state of the science and the hurdles that must be overcome to achieve successful angiogenesis/myogenesis
  • Journal Of Interventional Cardiology Review
  • Circulation Book Review
  • Science Book Review
  • JAMA Book Review

• Intramyocardial delivery provides a superior mode of delivery for therapeutic angiogenesis

• Dr Rana Reports on the powerful placebo effect in endstage coronary artery disease

• Dr Voisine Reports on the deleterious effect of elevated cholesterol on angiogenesis and endothelial function

• Dr Shie describes a Novel Transcriptional Stimulator of VEGF: RTEF-1

• Drs. Wu and Li report the antiapoptotic and myocardial protective effects of PR39

• Angiogenesis Research Center and Interventional cardiology Section receives a BIRD foundation grant to study a novel mechanism to induce angiogenesis: MicroTissue transplant for sustained and efficient angiogenesis

• Dr Ruel discusses the effect of elevated cholesterol on angiogenesis

• Dr Wu publishes on COX-2 cardioprotective effect

• Summer 2003 students, pictures from the labs

• ARC publishes on spatial heterogeneity in VEGF-iduced vasodilation

• Study at BIDMC discussed on Boston's WCVB

• Study at BIDMC discussed on New England Cable News

• Study at BIDMC discussed on BBC

• Cell Therapy for cardiovascular disease: fact or fiction. Editorial in Lancet

• The Angiogenesis Research Center is recruiting patients for several studies of therapeutic angiogenesis.

• The Angiogenesis Research Center reports on Phase II randomized, placebo controlled study of FGF-2

• The Angiogenesis Research Center reports on safer subxyhoid access strategies for pericardial drainage

• Angiogenesis Research Center characterize PR39 as a novel peptide regulator of angiogenesis

• Angiogenesis Research Center report of results of intrapericardial basic fibroblast growth factor in inducing functionally significant angiogenesis in ischemic myocardium

• Angiogenesis Research Center Staff Featured in National Center for Research Resources Reporter

• Angiogenesis Research Center offers a new treatment strategy that makes the heart more energy efficient (by inhibiting fatty acid metabolism and promoting glycolysis)

• Angiogenesis Research Center Staff report on gene transfer for heart disease

• Instead of fixing heart arteries with tools, some scientists are trying to persuade the body to take a "do-it-yourself" approach

• Angiogenesis Center Staff report on intrapericardial delivery for angiogenesis